N@N

Market Maker Surveillance Report. PSDV, SIGA, NWK, ARNA, OPXT, AOIFF, Winning Stocks With Lowest Price Friction For Monday, Ma

March 26, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 3557 companies with "abnormal" market making, 4179 companies with positive Friction Factors and 2010 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. PSIVIDA CORP (NASDAQ:PSDV), SIGA Technologies Inc (NASDAQ:SIGA), NETWORK EQUIPMENT TECH INC (NASDAQ:NWK), ARENA PHARMACEUTICALS INC (NASDAQ:ARNA), OPNEXT INC (NASDAQ:OPXT), AFRICA OIL CORP (OTC:AOIFF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  PSDV    $0.280    17.39%    73,892       64.79%    40,158       35.21%    33,734       1,205   
  SIGA    $0.910    33.70%    1,531,766    52.27%    1,397,739    47.70%    134,027      1,473   
  NWK     $0.200    20.71%    121,753      66.75%    76,660       42.03%    45,093       2,255   
  ARNA    $0.590    24.48%    30,398,462   51.90%    28,041,368   47.88%    2,357,094    39,951  
  OPXT    $0.730    66.97%    288,947      53.07%    255,527      46.93%    33,420       458     
  AOIFF   $1.000    42.19%    131,163      34.06%    122,195      31.73%    8,968        90      

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PSDV with a dollar gain Monday of $0.28000 and a Friction Factor of 1,205 shares. That means that it only took 1,205 more shares of buying than selling to move PSDV higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

PSIVIDA CORP (NASDAQ:PSDV) - pSivida Corp., together with its subsidiaries, develops drug delivery products that are administered by implantation, injection, or insertion. The companys lead product candidate is Iluvien, which is in Phase III clinical trials and delivers fluocinolone acetonide (FA) for the treatment of diabetic macular edema (DME), a cause of vision loss. It is also conducting Phase II clinical trials with Iluvien in wet and dry age-related macular degeneration. In addition, the companys products include Retisert, an intravitreal drug implant for the treatment of chronic non-infectious posterior uveitis; and Vitrasert for cytomegalovirus retinitis, a blinding eye disease that occurs in individuals with advanced AIDS. It is developing a series of additional miniaturized, bioerodible technologies, including BioSilicon technology, which is nano-structured porous silicon designed for use as a drug delivery platform; and Medidur technology, a miniaturized, injectable, sustained-release drug delivery system to advance the treatment of medical conditions in critical areas, such as ophthalmology, oncology, and cardiology. Further, the companys BioSilicon product candidates includes BrachySil, a brachytherapy product in development for the treatment of solid tumors; and completed an initial safety study of BrachySil for the treatment of pancreatic cancer and a dose ranging study. It has strategic collaborations with Bausch & Lomb Incorporated; Alimera Sciences, Inc.; Pfizer, Inc.; and Intrinsiq Materials Cayman Limited. The company was founded in 1987 and is headquartered in Watertown, Massachusetts.

SIGA Technologies Inc (NASDAQ:SIGA) - SIGA Technologies, Inc., a bio-defense company, engages in the discovery, development, and commercialization of products for use in defense against biological warfare agents comprising smallpox and arenaviruses. It also involves in the discovery and development of other novel anti-infectives and antibiotics for the prevention and treatment of serious infectious diseases. The company primarily offers ST-246, an orally administered antiviral drug that targets orthopox viruses. It also develops anti-arenavirus drug candidates, such as ST-294 and ST-193, which demonstrate antiviral activity in cell culture assays against arenavirus pathogens; and broad spectrum antiviral candidate, ST-669, against viruses in the Poxviridae, Filoviridae, Bunyaviridae, Arenaviridae, Flaviviridae, Togaviridae, Retroviridae, and Picornaviridae families. In addition, the company has four drug series in the pre-clinical development stage, including ST-610 and ST-148 for dengue virus of the genus Flavivirus. SIGA Technologies, Inc. was founded in 1995 and is headquartered in New York, New York.

NETWORK EQUIPMENT TECH INC (NASDAQ:NWK) - Network Equipment Technologies, Inc. (NET), together with its subsidiaries, engages in the design, development, manufacture, and sale of voice and data telecommunications equipment for multi-service networks and associated services used by government organizations, enterprises, and carriers worldwide. The company offers voice solutions that include the VX Series and the Quintum Series of switching media gateways that provide enterprise customers with voice interoperability solutions, IP-based solutions to government agencies, and traditional VoIP switching gateway solutions for SMBs and smaller branch offices within large enterprises. It offers multi-service solutions, which comprise Promina product line, a traditional multi-service platform, which provides network reliability and security; NX1000 platform that provides a WAN switching solution to enable multi-service and serial data applications to integrate and aggregate into IP-based networks; and NX5010 platform, which enables secure interconnection and extension of geographically distributed grid computing clusters and storage area networks, providing data transfer. The company also offers SmartSIP product that allows standard SIP phones to be provisioned and used as extensions in a Microsoft OCS deployment. NET provides installation and other professional services; hardware and software maintenance programs, parts repair, remote and on-site technical assistance, and customer training; and Web-based services. The company serves government customers, which include various federal and international agencies and organizations, such as civilian and defense agencies, and resellers to such entities; and enterprise customers comprising large enterprises, and small-to mid-sized businesses in various sectors. NET sells its products directly, as well as through relationships with integrators, resellers, and technology leaders. The company was founded in 1983 and is headquartered in Fremont, California.

ARENA PHARMACEUTICALS INC (NASDAQ:ARNA) - Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral drugs in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company also discovers small molecule drug candidates that target G protein-coupled receptors (GPCRs). Its clinical development programs include lorcaserin that has completed Phase III clinical trials for the treatment of weight management; APD791, an anti-thrombotic drug candidate, which completed Phase Ia and Phase Ib clinical trials; APD597 that is in Phase I clinical trials for the treatment of type II diabetes; APD916, which has completed preclinical development for the treatment of narcolepsy and cataplexy; and APD811, a preclinical drug candidate for the treatment of pulmonary arterial hypertension. The companys drug candidates use GPCR-focused drug discovery and development approach, as well as technologies, including Constitutively Activated Receptor Technology and Melanophore Technology. It has collaboration agreements with Ortho-McNeil-Janssen Pharmaceuticals, Inc. to further develop compounds for the potential treatment of type II diabetes and other disorders; and Merck & Co., Inc. to develop therapeutics for atherosclerosis and other disorders. Arena Pharmaceuticals also has a strategic cooperation agreement with Siegfried Ltd to manufacture lorcaserin. The company was founded in 1997 and is based in San Diego, California.

OPNEXT INC (NASDAQ:OPXT) - Opnext, Inc., together with its subsidiaries, designs and manufactures optical subsystems, modules, and components for communication uses primarily in North America, Europe, Japan, and Asia Pacific. The companys optical communications components consist of transmitters and receivers that include a hermetically packaged compound semiconductor laser or photo detectors, which utilize internally fabricated lasers or photo detectors built from indium phosphide or gallium arsenide compound semiconductor materials systems. Its optical transceiver modules convert signals between electrical and optical for transmitting and receiving data over fiber optic networks, and provide the physical communications interface for data communications and telecommunications systems. The optical transceiver modules are used for client-side interfaces consisting of short distance dedicated fiber cables, as well as line-side interfaces, which include long distance transmission with shared fiber cable and amplification media. Opnexts subsystems provide 40Gbps or 100Gbps long-distance optical communications. The companys customers include companies that design and manufacture laser-based products, including medical and scientific systems, industrial bar code scanners, professional grade construction and surveying tools, gun sights and other security equipment, display and projection systems for mini-projectors and other projection applications, sensors for robotics and industrial automation, and printing engines for high-speed laser printers and plain paper copiers. Opnext, Inc. founded in 2000 and is headquartered in Fremont, California.

AFRICA OIL CORP (OTC:AOIFF) - Africa Oil Corp. engages in the exploration, development, and production of oil and gas. It has oil interests in Ethiopia and Kenya, as well as Puntland, Somalia. The company was formerly known as Canmex Minerals Corporation and changed its name to Africa Oil Corp. in August 2007. Africa Oil Corp. was incorporated in 1983 and is headquartered in Vancouver, Canada.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net